Navigation Links
Mylan to Acquire Pfizer Respiratory Delivery Platform
Date:11/9/2011

PITTSBURGH, Nov. 9, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has entered into an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize Pfizer's generic equivalent to GlaxoSmithKline's Advair® Diskus and Seretide® Diskus incorporating Pfizer's proprietary dry powder inhaler delivery platform. Advair® Diskus and Seretide® Diskus are inhaled fixed-dose combinations of Fluticasone Propionate and Salmeterol delivered via a dry powder inhaler and are used to treat asthma and COPD (chronic obstructive pulmonary disorder).

In addition, Pfizer will grant Mylan rights to its dry-powder delivery platform to develop and commercialize additional brand and generic pharmaceutical products, including rights of negotiation for certain existing Pfizer compounds currently in various stages of development.

In connection with the transaction, Mylan will employ select key members of the former Pfizer respiratory inhalation development team based at Discovery Park in Sandwich, U.K., where Mylan will establish a respiratory development division. Some employees also will be based in Cambridge, U.K.

Mylan Chairman and CEO Robert J. Coury said: "Mylan's acquisition of rights to Pfizer's inhalation technology platform delivers on yet another one of our key strategic objectives by filling an important gap in our product portfolio and builds a truly world-class respiratory franchise for Mylan. I would like to personally welcome to Mylan the talented former Pfizer employees who will be joining us. This team's core competency in respiratory brings Mylan deep knowledge and expertise that will allow us to fully leverage this exciting delivery platform. We will be establishing a 'center of excellence' in respiratory at Discovery Park in Sandwich and believe this franchise will serve as an additional co
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 Educating the community continues to ... the Advancement of Wound Care (AAWC), which was ... AAWC,s corporate partners, the Association provides medical professionals ... AAWC website at http://aawconline.org/education-for-the-generalist/ . The portal ... links to various CME/CEU educational programs. This education ...
(Date:5/28/2015)... HOUSTON , May 28, 2015 /PRNewswire/ - ESSA Pharma ... results for the second quarter and three and six months ... in Canadian dollars and in accordance with International Financial Reporting ... ESSA recorded a net loss of $5.9 million ($0.35 per ... (Q2-2015), compared to a net loss of $0.4 million ($0.03 ...
(Date:5/28/2015)... 2015  Maetrics ( http://maetrics.com ), a leading international ... up a successful conference, "The cost of non-compliance -- How ... in Zurich . ... Switzerland -based team, experts provided insights ... field to an exclusive local audience. The event was ...
Breaking Medicine Technology:The Association for the Advancement of Wound Care Educates the Public 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
... 5 GlaxoSmithKline [NYSE: GSK] today announced that ... Oncologic Drugs Advisory Committee (ODAC) voted unanimously in ... the panel voted that the benefit-to-risk profile is ... (RCC). Pazopanib is an investigational, oral treatment for ...
... Oct. 5 In a settlement that is essentially ... (NLRB), which conducted a two-month investigation into massive illegal ... company, the giant HCA chain, have pledged to end ... of registered nurses. , The settlement stems from a ...
Cached Medicine Technology:GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM) 2GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM) 3Faced With Federal Prosecution, MountainView Agrees to Stop Harassment of RNs in Settlement With Labor Board 2
(Date:5/29/2015)... Intermountain Healthcare of Salt ... Stratus Video Interpreting for on-demand medical ... and timely care for patients with limited ... video remote interpreting (VRI) services will supplement ... quickly access qualified medical interpretation in nearly ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... USA Today, with a circulation of approximately 250,000 and ... distributed nationally, through a vast social media strategy, and ... outlets. To explore the digital version of the campaign, ... cover of the print publication. Inside, the actress, model ...
(Date:5/29/2015)... Mediaplanet has joined forces with Colorescience ... Skin Health is a cross-platform campaign with a national ... New York, Los Angeles, and Chicago, the campaign is ... counterpart will reach a national audience through one of ... Skin Health campaign and Colorescience, click here . ...
(Date:5/29/2015)... May 29, 2015 OncLive proudly announces ... dozen medical pioneers recognized by a panel of eminent ... of cancer treatment. Honorees will be introduced and celebrated ... Award Ceremony, held 8:30-11:00 p.m. CDT at The Chicago ... honorees are being recognized for groundbreaking accomplishments, in fields ...
(Date:5/29/2015)... May 29, 2015 Healthpointe is ... with specialists, physical therapy, and injections , For ... back and/or lower back pain, Healthpointe has a ... for herniated discs, disc protrusions and other causes ... , Healthpointe’s team of renowned surgeons are now ...
Breaking Medicine News(10 mins):Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3
... Researchers from Harvard School of Public Health (HSPH), Massachusetts ... Research (NBER), and Providence Health & Services have found ... increases health care use, reduces financial strain on covered ... is the first study to evaluate the impact of ...
... today [Thursday 7 July] at the Annual Scientific Meeting of ... the Academic Unit of Primary Health Care, University of Bristol. ... 2008, uses HPV vaccine that is effective against the two ... offers 70 per cent protection against cervical cancer. However, ...
... 6, 2011) One consequence of the expanded access to ... shortfall in the necessary numbers of physicians and other advanced ... issue of the Journal of the American College of ... the combined workforce of physicians, advance practice nurses, and physician ...
... HealthDay Reporter , WEDNESDAY, July 6 (HealthDay ... multiple sclerosis have been dimmed by recent research in ... found no support for prior studies connecting breast-feeding with ... disorder commonly known as MS. Instead, they ...
... , WEDNESDAY, July 6 (HealthDay News) -- Airline pilots ... debilitating fatigue that could hamper their flying performance, a ... U.S. Federal Aviation Administration should find ways to reduce ... to the report from the U.S. National Research Council. ...
... HealthDay Reporter , WEDNESDAY, July 6 (HealthDay News) -- ... rise in various parts of the country, and this one ... by a microscopic parasite that attacks blood cells, causing flu-like ... Lyme disease, which is caused by bacteria, babesia microti parasites ...
Cached Medicine News:Health News:Medicaid increases use of health care, decreases financial strain, improves health 2Health News:Medicaid increases use of health care, decreases financial strain, improves health 3Health News:Lack of clarity about HPV vaccine and the need for cervical cancer screening 2Health News:Future labor shortfalls of medical professionals predicted due to new demands of health-care reform 2Health News: Breast-Feeding May Not Protect Moms Against MS Relapse 2Health News: Breast-Feeding May Not Protect Moms Against MS Relapse 3Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 2Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 3Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 4Health News:A Deadly New Reason to Avoid Deer Ticks 2Health News:A Deadly New Reason to Avoid Deer Ticks 3
... mg/kg sulfate (SO 4 ) ≤ 1000 mg/kg Cation ... Co ≤ 5 mg/kg Cr ≤ 10 mg/kg Cu ... 5 mg/kg Mg ≤ 5 mg/kg Mn ≤ 5 ... Pb ≤ 5 mg/kg Zn ≤ 5 mg/kg Special ...
Inquire...
... A low temperature agarose for special ... Optimal for in-gel restriction digestion/ligation and DNA ... manageable clear gel that provides excellent resolution ... 65°C and remains fluid at 37°C for ...
... Agarose 3:1 HRB™ (High Resolution Blend), ... to provide high resolution of small nucleic ... analysis of DNA fragmanets less than 1,000 ... patterns without smearing of high background fluorescence. ...
Medicine Products: